Sirius NeoSight

Lyon, France

Sirius NeoSight is a biotech and pharmaceutical company that detects subclinical neo-cancers and provide treatment for it.

$4.6M raised

Feb 2025

Seed

Biopharma Biotechnology Health Care

Top Investors

GO CAPITAL Demeter Better Angle Evolem Start Angels Santé

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sirius NeoSight

How much funding has Sirius NeoSight raised?

Sirius NeoSight has raised $4.6M in total funding. The most recent round was Seed. The last funding was announced in February 2025.

Who are Sirius NeoSight's investors?

Sirius NeoSight's investors include GO CAPITAL, Demeter, Better Angle, Evolem Start, Angels Santé.

Where is Sirius NeoSight headquartered?

Sirius NeoSight is headquartered in Lyon, France.

What does Sirius NeoSight do?

Sirius NeoSight is a biotech and pharmaceutical company that detects subclinical neo-cancers and provide treatment for it.

What stage is Sirius NeoSight at?

Sirius NeoSight is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 4, 2025.

MLA

"Sirius NeoSight — Funding & Investors." VCBacked, February 4, 2025, https://www.vcbacked.co/company/sirius-neosight. Accessed July 2, 2026.

APA

VCBacked. (2025). Sirius NeoSight — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/sirius-neosight

Wikipedia (cite web)

{{cite web |title=Sirius NeoSight — Funding & Investors |url=https://www.vcbacked.co/company/sirius-neosight |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 4, 2025.

Similar Companies in Biopharma

View all

Allterum Therapeutics

Living In Silico Inc.